A Study of BTX-1188 in Subjects With Advanced Malignancies

Clinical trial NCT05144334 · TERMINATED

Trial details

NCT number: NCT05144334
Sponsor: Biotheryx, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Non Hodgkin Lymphoma Acute Myeloid Leukemia

Start date: 2022-01-24
Primary completion: 2023-09-12
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.